Risk factors for recurrence of hepatocellular carcinoma after radiofrequency ablation in a cohort of Egyptian patients with hepatitis C virus-induced cirrhosis

Sharaf-Eldin, Mohamed; S, El-Yamany; Salah, Raafat Abdelkader; Kohla, Mohamed; Habba, Eslam; Fattah, Hisham A.; Ghazy, Mohamed Shaker

doi:10.1097/01.elx.0000440962.37421.c8

Cited by 1 publication

(1 citation statement)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, Kamal et al [ 144 ] found no difference between MWA ablation and RFA ablation in treating HCC. Due to the high incidence of HCC related HCV in Egypt, the high risk of recurrence in those patients was investigated by Sharaf-Eldin et al [ 145 ]. The study concluded that in those patients, the presence of hepatomegaly, heterogenous liver, and splenomegaly, a sign of portal hypertension, together with tumor factors such as large size, bilobar affliction, and lesions near the liver capsule, showed a significant association with tumor recurrence.…”

Section: Treatment Of Hcc In Egyptmentioning

confidence: 99%

Unique situation of hepatocellular carcinoma in Egypt: A review of epidemiology and control measures

Ezzat¹,

Eltabbakh²,

Kassas³

2021

WJGO

View full text Add to dashboard Cite

Hepatocellular carcinoma (HCC) is the sixth most common primary malignancy worldwide, and the third most common cause of death among cancers worldwide. HCC occurs in several pre-existing conditions, including hepatitis C, hepatitis B virus, and non-alcoholic cirrhosis. Egypt used to be the country with the heaviest hepatitis C virus (HCV) burden. The relationship between HCV and HCC is an important research area. In Egypt, HCC is a significant public health problem. A possible cause for the increasing rates of detection of HCC in Egypt is the mass screening program that was carried by the government for detecting and treating HCV. A multidisciplinary approach is now widely applied to HCC management in health centers all over Egypt. Different treatment modalities are available in Egypt, with success rates comparable to global rates. The Egyptian health authorities have made the elimination of HCV from Egypt a special priority, and this approach should lead to a decrease in number of HCC cases in the near future. In this article we review the current situation of HCC in Egypt, including epidemiological aspects, relevant risk factors for HCC development, strategies, and efforts established by health authorities for the screening and prevention of both HCV and HCC in Egypt. We highlight the different modalities for HCC treatment.

show abstract

Section: Treatment Of Hcc In Egyptmentioning

confidence: 99%